Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that on October 22, 2024, the ...

Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, continues to empower parents with increased access to prenatal testing. SneakPeek, the #1 OBGYN-recommended ...

Positive clinical data with confirmed overall response rate (ORR) = 62.5% (95% CI, 30.4-86.5) and prospective ACR-368 OncoSignature patient ...

NEW YORK--(BUSINESS WIRE)--PartnerCentric, a leader in performance-driven affiliate marketing, launches two powerful ...

Cash position at September 30, 2024 was $1.3 million. The company announced on October 25, 2024, the exercise of outstanding warrants resulting in gross proceeds of $4.9 million. David Jenkins, CEO of ...

Discover why dirty data undermines B2B marketing efforts and learn ways to improve data quality to drive effective campaigns ...

X50, the revolutionary silicone material for the Lumia X1. Unlock the potential of direct 3D printed silicone for healthcare ...

Alcon launched a disposable lens product for astigmatism patients, named ‘Precision 1’, in January 2021. The lenses are ...

TMR2615/TMR2617 are powered by MDT's proprietary TMR technology, integrated with a programmable ASIC offering factory-preset ...